Literature DB >> 23954108

Population-based analysis of Alzheimer's disease risk alleles implicates genetic interactions.

Mark T W Ebbert1, Perry G Ridge1, Andrew R Wilson2, Aaron R Sharp3, Matthew Bailey3, Maria C Norton4, JoAnn T Tschanz5, Ronald G Munger6, Christopher D Corcoran7, John S K Kauwe8.   

Abstract

BACKGROUND: Reported odds ratios and population attributable fractions (PAF) for late-onset Alzheimer's disease (LOAD) risk loci (BIN1, ABCA7, CR1, MS4A4E, CD2AP, PICALM, MS4A6A, CD33, and CLU) come from clinically ascertained samples. Little is known about the combined PAF for these LOAD risk alleles and the utility of these combined markers for case-control prediction. Here we evaluate these loci in a large population-based sample to estimate PAF and explore the effects of additive and nonadditive interactions on LOAD status prediction performance.
METHODS: 2419 samples from the Cache County Memory Study were genotyped for APOE and nine LOAD risk loci from AlzGene.org. We used logistic regression and receiver operator characteristic analysis to assess the LOAD status prediction performance of these loci using additive and nonadditive models and compared odds ratios and PAFs between AlzGene.org and Cache County.
RESULTS: Odds ratios were comparable between Cache County and AlzGene.org when identical single nucleotide polymorphisms were genotyped. PAFs from AlzGene.org ranged from 2.25% to 37%; those from Cache County ranged from .05% to 20%. Including non-APOE alleles significantly improved LOAD status prediction performance (area under the curve = .80) over APOE alone (area under the curve = .78) when not constrained to an additive relationship (p < .03). We identified potential allelic interactions (p values uncorrected): CD33-MS4A4E (synergy factor = 5.31; p < .003) and CLU-MS4A4E (synergy factor = 3.81; p < .016).
CONCLUSIONS: Although nonadditive interactions between loci significantly improve diagnostic ability, the improvement does not reach the desired sensitivity or specificity for clinical use. Nevertheless, these results suggest that understanding gene-gene interactions may be important in resolving Alzheimer's disease etiology.
Copyright © 2014 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; epistasis; genetic interactions; odds ratio; population attributable fraction; risk

Mesh:

Substances:

Year:  2013        PMID: 23954108      PMCID: PMC3867586          DOI: 10.1016/j.biopsych.2013.07.008

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  34 in total

Review 1.  Epistasis: what it means, what it doesn't mean, and statistical methods to detect it in humans.

Authors:  Heather J Cordell
Journal:  Hum Mol Genet       Date:  2002-10-01       Impact factor: 6.150

2.  Alzheimer's disease genes and cognition in the nondemented general population.

Authors:  Benjamin F J Verhaaren; Meike W Vernooij; Peter J Koudstaal; André G Uitterlinden; Cornelia M van Duijn; Albert Hofman; Monique M B Breteler; M Arfan Ikram
Journal:  Biol Psychiatry       Date:  2012-05-15       Impact factor: 13.382

Review 3.  Case-control studies in the genomic era: a clinician's guide.

Authors:  Daniel G Healy
Journal:  Lancet Neurol       Date:  2006-08       Impact factor: 44.182

Review 4.  Epistasis in sporadic Alzheimer's disease.

Authors:  Onofre Combarros; Mario Cortina-Borja; A David Smith; Donald J Lehmann
Journal:  Neurobiol Aging       Date:  2008-02-21       Impact factor: 4.673

5.  Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City.

Authors:  M X Tang; G Maestre; W Y Tsai; X H Liu; L Feng; W Y Chung; M Chun; P Schofield; Y Stern; B Tycko; R Mayeux
Journal:  Am J Hum Genet       Date:  1996-03       Impact factor: 11.025

6.  Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease.

Authors:  Denise Harold; Richard Abraham; Paul Hollingworth; Rebecca Sims; Amy Gerrish; Marian L Hamshere; Jaspreet Singh Pahwa; Valentina Moskvina; Kimberley Dowzell; Amy Williams; Nicola Jones; Charlene Thomas; Alexandra Stretton; Angharad R Morgan; Simon Lovestone; John Powell; Petroula Proitsi; Michelle K Lupton; Carol Brayne; David C Rubinsztein; Michael Gill; Brian Lawlor; Aoibhinn Lynch; Kevin Morgan; Kristelle S Brown; Peter A Passmore; David Craig; Bernadette McGuinness; Stephen Todd; Clive Holmes; David Mann; A David Smith; Seth Love; Patrick G Kehoe; John Hardy; Simon Mead; Nick Fox; Martin Rossor; John Collinge; Wolfgang Maier; Frank Jessen; Britta Schürmann; Reinhard Heun; Hendrik van den Bussche; Isabella Heuser; Johannes Kornhuber; Jens Wiltfang; Martin Dichgans; Lutz Frölich; Harald Hampel; Michael Hüll; Dan Rujescu; Alison M Goate; John S K Kauwe; Carlos Cruchaga; Petra Nowotny; John C Morris; Kevin Mayo; Kristel Sleegers; Karolien Bettens; Sebastiaan Engelborghs; Peter P De Deyn; Christine Van Broeckhoven; Gill Livingston; Nicholas J Bass; Hugh Gurling; Andrew McQuillin; Rhian Gwilliam; Panagiotis Deloukas; Ammar Al-Chalabi; Christopher E Shaw; Magda Tsolaki; Andrew B Singleton; Rita Guerreiro; Thomas W Mühleisen; Markus M Nöthen; Susanne Moebus; Karl-Heinz Jöckel; Norman Klopp; H-Erich Wichmann; Minerva M Carrasquillo; V Shane Pankratz; Steven G Younkin; Peter A Holmans; Michael O'Donovan; Michael J Owen; Julie Williams
Journal:  Nat Genet       Date:  2009-09-06       Impact factor: 38.330

7.  Genetic variation in apolipoprotein D affects the risk of Alzheimer disease in African-Americans.

Authors:  Purnima P Desai; Hugh C Hendrie; Rebecca M Evans; Jill R Murrell; Steven T DeKosky; M Ilyas Kamboh
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2003-01-01       Impact factor: 3.568

8.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

9.  Mitochondrial genomic analysis of late onset Alzheimer's disease reveals protective haplogroups H6A1A/H6A1B: the Cache County Study on Memory in Aging.

Authors:  Perry G Ridge; Taylor J Maxwell; Christopher D Corcoran; Maria C Norton; Joann T Tschanz; Elizabeth O'Brien; Richard A Kerber; Richard M Cawthon; Ronald G Munger; John S K Kauwe
Journal:  PLoS One       Date:  2012-09-17       Impact factor: 3.240

10.  Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

Authors:  Adam C Naj; Gyungah Jun; Gary W Beecham; Li-San Wang; Badri Narayan Vardarajan; Jacqueline Buros; Paul J Gallins; Joseph D Buxbaum; Gail P Jarvik; Paul K Crane; Eric B Larson; Thomas D Bird; Bradley F Boeve; Neill R Graff-Radford; Philip L De Jager; Denis Evans; Julie A Schneider; Minerva M Carrasquillo; Nilufer Ertekin-Taner; Steven G Younkin; Carlos Cruchaga; John S K Kauwe; Petra Nowotny; Patricia Kramer; John Hardy; Matthew J Huentelman; Amanda J Myers; Michael M Barmada; F Yesim Demirci; Clinton T Baldwin; Robert C Green; Ekaterina Rogaeva; Peter St George-Hyslop; Steven E Arnold; Robert Barber; Thomas Beach; Eileen H Bigio; James D Bowen; Adam Boxer; James R Burke; Nigel J Cairns; Chris S Carlson; Regina M Carney; Steven L Carroll; Helena C Chui; David G Clark; Jason Corneveaux; Carl W Cotman; Jeffrey L Cummings; Charles DeCarli; Steven T DeKosky; Ramon Diaz-Arrastia; Malcolm Dick; Dennis W Dickson; William G Ellis; Kelley M Faber; Kenneth B Fallon; Martin R Farlow; Steven Ferris; Matthew P Frosch; Douglas R Galasko; Mary Ganguli; Marla Gearing; Daniel H Geschwind; Bernardino Ghetti; John R Gilbert; Sid Gilman; Bruno Giordani; Jonathan D Glass; John H Growdon; Ronald L Hamilton; Lindy E Harrell; Elizabeth Head; Lawrence S Honig; Christine M Hulette; Bradley T Hyman; Gregory A Jicha; Lee-Way Jin; Nancy Johnson; Jason Karlawish; Anna Karydas; Jeffrey A Kaye; Ronald Kim; Edward H Koo; Neil W Kowall; James J Lah; Allan I Levey; Andrew P Lieberman; Oscar L Lopez; Wendy J Mack; Daniel C Marson; Frank Martiniuk; Deborah C Mash; Eliezer Masliah; Wayne C McCormick; Susan M McCurry; Andrew N McDavid; Ann C McKee; Marsel Mesulam; Bruce L Miller; Carol A Miller; Joshua W Miller; Joseph E Parisi; Daniel P Perl; Elaine Peskind; Ronald C Petersen; Wayne W Poon; Joseph F Quinn; Ruchita A Rajbhandary; Murray Raskind; Barry Reisberg; John M Ringman; Erik D Roberson; Roger N Rosenberg; Mary Sano; Lon S Schneider; William Seeley; Michael L Shelanski; Michael A Slifer; Charles D Smith; Joshua A Sonnen; Salvatore Spina; Robert A Stern; Rudolph E Tanzi; John Q Trojanowski; Juan C Troncoso; Vivianna M Van Deerlin; Harry V Vinters; Jean Paul Vonsattel; Sandra Weintraub; Kathleen A Welsh-Bohmer; Jennifer Williamson; Randall L Woltjer; Laura B Cantwell; Beth A Dombroski; Duane Beekly; Kathryn L Lunetta; Eden R Martin; M Ilyas Kamboh; Andrew J Saykin; Eric M Reiman; David A Bennett; John C Morris; Thomas J Montine; Alison M Goate; Deborah Blacker; Debby W Tsuang; Hakon Hakonarson; Walter A Kukull; Tatiana M Foroud; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Lindsay A Farrer; Gerard D Schellenberg
Journal:  Nat Genet       Date:  2011-04-03       Impact factor: 38.330

View more
  31 in total

1.  An efficient gene-gene interaction test for genome-wide association studies in trio families.

Authors:  Pei-Yuan Sung; Yi-Ting Wang; Ya-Wen Yu; Ren-Hua Chung
Journal:  Bioinformatics       Date:  2016-02-11       Impact factor: 6.937

2.  A Weighted Genetic Risk Score Based on Four APOE-Independent Alzheimer's Disease Risk Loci May Supplement APOE E4 for Better Disease Prediction.

Authors:  Chunyu Zhang; Riletemuer Hu; Guohua Zhang; Yan Zhe; Baolige Hu; Juan He; Zhiguang Wang; Xiaokun Qi
Journal:  J Mol Neurosci       Date:  2019-07-25       Impact factor: 3.444

3.  Sex Differences in Risk for Alzheimer's Disease Related to Neurotrophin Gene Polymorphisms: The Cache County Memory Study.

Authors:  Joshua Matyi; JoAnn T Tschanz; Gail B Rattinger; Chelsea Sanders; Elizabeth K Vernon; Chris Corcoran; John S K Kauwe; Mona Buhusi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-11-09       Impact factor: 6.053

4.  Population-based analysis of cholesteryl ester transfer protein identifies association between I405V and cognitive decline: the Cache County Study.

Authors:  Caitlin Lythgoe; Ammon Perkes; Michael Peterson; Cameron Schmutz; Maegan Leary; Mark T W Ebbert; Perry G Ridge; Maria C Norton; JoAnn T Tschanz; Ronald G Munger; Christopher D Corcoran; John S K Kauwe
Journal:  Neurobiol Aging       Date:  2014-08-27       Impact factor: 4.673

5.  A multivariate model of time to conversion from mild cognitive impairment to Alzheimer's disease.

Authors:  María Eugenia López; Agustín Turrero; Pablo Cuesta; Inmaculada Concepción Rodríguez-Rojo; Ana Barabash; Alberto Marcos; Fernando Maestú; Alberto Fernández
Journal:  Geroscience       Date:  2020-09-04       Impact factor: 7.713

Review 6.  Genetics of Alzheimer's Disease: the Importance of Polygenic and Epistatic Components.

Authors:  Neha Raghavan; Giuseppe Tosto
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-21       Impact factor: 5.081

Review 7.  A multiomics approach to heterogeneity in Alzheimer's disease: focused review and roadmap.

Authors:  AmanPreet Badhwar; G Peggy McFall; Shraddha Sapkota; Sandra E Black; Howard Chertkow; Simon Duchesne; Mario Masellis; Liang Li; Roger A Dixon; Pierre Bellec
Journal:  Brain       Date:  2020-05-01       Impact factor: 13.501

8.  Assessment of TREM2 rs75932628 association with Alzheimer's disease in a population-based sample: the Cache County Study.

Authors:  Josue D Gonzalez Murcia; Cameron Schmutz; Caitlin Munger; Ammon Perkes; Aaron Gustin; Michael Peterson; Mark T W Ebbert; Maria C Norton; Joann T Tschanz; Ronald G Munger; Christopher D Corcoran; John S K Kauwe
Journal:  Neurobiol Aging       Date:  2013-07-12       Impact factor: 4.673

9.  Evaluation of a Genetic Risk Score to Improve Risk Prediction for Alzheimer's Disease.

Authors:  Vincent Chouraki; Christiane Reitz; Fleur Maury; Joshua C Bis; Celine Bellenguez; Lei Yu; Johanna Jakobsdottir; Shubhabrata Mukherjee; Hieab H Adams; Seung Hoan Choi; Eric B Larson; Annette Fitzpatrick; Andre G Uitterlinden; Philip L de Jager; Albert Hofman; Vilmundur Gudnason; Badri Vardarajan; Carla Ibrahim-Verbaas; Sven J van der Lee; Oscar Lopez; Jean-François Dartigues; Claudine Berr; Philippe Amouyel; David A Bennett; Cornelia van Duijn; Anita L DeStefano; Lenore J Launer; M Arfan Ikram; Paul K Crane; Jean-Charles Lambert; Richard Mayeux; Sudha Seshadri
Journal:  J Alzheimers Dis       Date:  2016-06-18       Impact factor: 4.472

Review 10.  Etiology and pathogenesis of late-onset Alzheimer's disease.

Authors:  Brian J Balin; Alan P Hudson
Journal:  Curr Allergy Asthma Rep       Date:  2014-03       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.